224 related articles for article (PubMed ID: 32056741)
1. The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.
Mathai DS; Meyer MJ; Storch EA; Kosten TR
J Affect Disord; 2020 Mar; 264():123-129. PubMed ID: 32056741
[TBL] [Abstract][Full Text] [Related]
2. Do the dissociative side effects of ketamine mediate its antidepressant effects?
Luckenbaugh DA; Niciu MJ; Ionescu DF; Nolan NM; Richards EM; Brutsche NE; Guevara S; Zarate CA
J Affect Disord; 2014 Apr; 159():56-61. PubMed ID: 24679390
[TBL] [Abstract][Full Text] [Related]
3. Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.
Niciu MJ; Shovestul BJ; Jaso BA; Farmer C; Luckenbaugh DA; Brutsche NE; Park LT; Ballard ED; Zarate CA
J Affect Disord; 2018 May; 232():310-315. PubMed ID: 29501990
[TBL] [Abstract][Full Text] [Related]
4. Ketamine administration in depressive disorders: a systematic review and meta-analysis.
Fond G; Loundou A; Rabu C; Macgregor A; Lançon C; Brittner M; Micoulaud-Franchi JA; Richieri R; Courtet P; Abbar M; Roger M; Leboyer M; Boyer L
Psychopharmacology (Berl); 2014 Sep; 231(18):3663-76. PubMed ID: 25038867
[TBL] [Abstract][Full Text] [Related]
5. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression.
Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP
J Psychiatr Res; 2018 Nov; 106():61-68. PubMed ID: 30278319
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of antidepressant and anti-suicidal effects of repeated ketamine infusions in elderly and younger adults with depression.
Zheng W; Zhou YL; Wang CY; Lan XF; Ning YP
J Affect Disord; 2023 Aug; 334():145-151. PubMed ID: 37160235
[TBL] [Abstract][Full Text] [Related]
7. A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions.
Rodrigues NB; McIntyre RS; Lipsitz O; Lee Y; Cha DS; Shekotikhina M; Vinberg M; Gill H; Subramaniapillai M; Kratiuk K; Lin K; Ho R; Mansur RB; Rosenblat JD
J Affect Disord; 2021 Mar; 282():160-164. PubMed ID: 33418362
[TBL] [Abstract][Full Text] [Related]
8. The Relationship Between Acute Dissociative Effects Induced by Ketamine and Treatment Response in Adolescent Patients with Treatment-Resistant Depression.
Lineham A; Avila-Quintero VJ; Bloch MH; Dwyer J
J Child Adolesc Psychopharmacol; 2023 Feb; 33(1):20-26. PubMed ID: 36799961
[No Abstract] [Full Text] [Related]
9. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
[TBL] [Abstract][Full Text] [Related]
10. Dissociative symptoms with intravenous ketamine in treatment-resistant depression exploratory observational study.
Włodarczyk A; Cubała WJ; Gałuszko-Węgielnik M; Szarmach J
Medicine (Baltimore); 2021 Jul; 100(29):e26769. PubMed ID: 34398056
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression.
Acevedo-Diaz EE; Cavanaugh GW; Greenstein D; Kraus C; Kadriu B; Zarate CA; Park LT
J Affect Disord; 2020 Feb; 263():568-575. PubMed ID: 31791675
[TBL] [Abstract][Full Text] [Related]
12. Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale.
van Schalkwyk GI; Wilkinson ST; Davidson L; Silverman WK; Sanacora G
J Affect Disord; 2018 Feb; 227():11-16. PubMed ID: 29045915
[TBL] [Abstract][Full Text] [Related]
13. Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.
Sos P; Klirova M; Novak T; Kohutova B; Horacek J; Palenicek T
Neuro Endocrinol Lett; 2013; 34(4):287-93. PubMed ID: 23803871
[TBL] [Abstract][Full Text] [Related]
14. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.
Zarate CA; Brutsche N; Laje G; Luckenbaugh DA; Venkata SL; Ramamoorthy A; Moaddel R; Wainer IW
Biol Psychiatry; 2012 Aug; 72(4):331-8. PubMed ID: 22516044
[TBL] [Abstract][Full Text] [Related]
15. A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression.
Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Lan XF; Zhang B; Ning YP
J Affect Disord; 2020 Oct; 275():38-43. PubMed ID: 32658821
[TBL] [Abstract][Full Text] [Related]
16. Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review.
Grabski M; Borissova A; Marsh B; Morgan CJA; Curran HV
Behav Brain Res; 2020 Aug; 392():112629. PubMed ID: 32485203
[TBL] [Abstract][Full Text] [Related]
17. Acute Dissociation and Ketamine's Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-Controlled Trial.
Sajid S; Galfalvy HC; Keilp JG; Burke AK; Mann JJ; Grunebaum MF
Int J Neuropsychopharmacol; 2024 Apr; 27(4):. PubMed ID: 38573154
[TBL] [Abstract][Full Text] [Related]
18. Safety and Tolerability of Ketamine Use in Treatment-Resistant Bipolar Depression Patients with Regard to Central Nervous System Symptomatology: Literature Review and Analysis.
Włodarczyk A; Cubała WJ
Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32050466
[TBL] [Abstract][Full Text] [Related]
19. Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder.
Aust S; Gärtner M; Basso L; Otte C; Wingenfeld K; Chae WR; Heuser-Collier I; Regen F; Cosma NC; van Hall F; Grimm S; Bajbouj M
Eur Neuropsychopharmacol; 2019 Apr; 29(4):529-538. PubMed ID: 30772118
[TBL] [Abstract][Full Text] [Related]
20. Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects.
Le TT; Di Vincenzo JD; Teopiz KM; Lee Y; Cha DS; Lui LMW; Rodrigues NB; Ho RC; Cao B; Lin K; Nasri F; Gill H; Lipsitz O; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
Psychiatry Res; 2021 Dec; 306():114231. PubMed ID: 34798487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
